Cargando…

SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells

As melanoma cells are immunogenic, they instigate an adaptive immune response and production of anti-tumor T-cells. A central factor in this interaction is CEACAM1 (carcinoembryonic antigen cell adhesion molecule 1), a transmembrane glycoprotein previously shown in our lab to protect melanoma cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashkenazi, Shira, Ortenberg, Rona, Besser, Michal, Schachter, Jacob, Markel, Gal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper: Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058672/ https://www.ncbi.nlm.nih.gov/pubmed/26885752 http://dx.doi.org/10.18632/oncotarget.7379

Ejemplares similares

CEACAM1 Promotes Melanoma Cell Growth through Sox-2()()
por: Ortenberg, Rona, et al.
Publicado: (2014)

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()
por: Kfir-Elirachman, Karin, et al.
Publicado: (2018)

Serum CEACAM1 Correlates with Disease Progression and Survival in Malignant Melanoma Patients
por: Sivan, Sapoznik, et al.
Publicado: (2012)

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms
por: Sapoznik, Sivan, et al.
Publicado: (2012)

Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy
por: Ortenberg, R., et al.
Publicado: (2015)

ADAR1-mediated regulation of melanoma invasion
por: Nemlich, Yael, et al.
Publicado: (2018)

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs
por: Greenberg, Eyal, et al.
Publicado: (2011)

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies
por: Besser, Michal J., et al.
Publicado: (2013)

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme
por: Galore-Haskel, Gilli, et al.
Publicado: (2015)

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma
por: Itzhaki, Orit, et al.
Publicado: (2013)

CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis
por: Markel, Gal, et al.
Publicado: (2016)

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions
por: Baruch, Erez Nissim, et al.
Publicado: (2020)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells
por: Markel, Gal, et al.
Publicado: (2009)

CEACAM1-Mediated Inhibition of Virus Production
por: Vitenshtein, Alon, et al.
Publicado: (2016)

CEACAM1 is a direct SOX10 target and inhibits melanoma immune infiltration and stemness
por: Abou-Hamad, John, et al.
Publicado: (2022)

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex
por: Greenberg, Eyal, et al.
Publicado: (2014)

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma
por: Galore-Haskel, Gilli, et al.
Publicado: (2017)

miR-17 regulates melanoma cell motility by inhibiting the translation of ETV1
por: Cohen, Ronit, et al.
Publicado: (2015)

Interactions of pathogenic Escherichia coli with CEACAMs
por: Sheikh, Alaullah, et al.
Publicado: (2023)

CEACAM expression in an in-vitro prostatitis model
por: Kube-Golovin, Irina, et al.
Publicado: (2023)

Focus on Adoptive T Cell Transfer Trials in Melanoma
por: Hershkovitz, Liat, et al.
Publicado: (2010)

Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
por: Weinstein-Marom, Hadas, et al.
Publicado: (2021)

90. Fecal Microbiota Transplantation in Metastatic Melanoma Patients Resistant to Anti-PD-1 Treatment
por: Youngster, Ilan, et al.
Publicado: (2019)

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
por: Rozenbaum, Meir, et al.
Publicado: (2020)

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
por: Asher, Nethanel, et al.
Publicado: (2021)

Comprehensive analysis, immune, and cordycepin regulation for SOX9 expression in pan-cancers and the matched healthy tissues
por: Liu, Shuguang, et al.
Publicado: (2023)

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy
por: Yunger, Sharon, et al.
Publicado: (2019)

Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils
por: Ribon, Matthieu, et al.
Publicado: (2019)

CEACAM3—A Prim(at)e Invention for Opsonin-Independent Phagocytosis of Bacteria
por: Bonsignore, Patrizia, et al.
Publicado: (2020)

Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis
por: Matsumoto, Haruki, et al.
Publicado: (2022)

Effects of Helicobacter pylori adhesin HopQ binding to CEACAM receptors in the human stomach
por: Nguyen, Quynh Anh, et al.
Publicado: (2023)

Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1
por: Diab, Mohammad, et al.
Publicado: (2016)

Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses
por: Singer, Bernhard B., et al.
Publicado: (2014)

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
por: Asher, Nethanel, et al.
Publicado: (2020)

Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns
por: Haik, Josef, et al.
Publicado: (2015)

TGF-β Signaling Promotes Glioma Progression Through Stabilizing Sox9
por: Chao, Min, et al.
Publicado: (2021)

Notch signaling controls chondrocyte hypertrophy via indirect regulation of Sox9
por: Kohn, Anat, et al.
Publicado: (2015)

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy
por: Nissani, Abraham, et al.
Publicado: (2021)

CEACAM1-4L Promotes Anchorage-Independent Growth in Melanoma
por: Löffek, Stefanie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_v574uiico6jvc2au0l0ol129f0